THE

DOSE

Daily news for smarter treatment decisions.

Latest Stories

Editorial cartoon: trending up arrow on teal/yellow waves

CMS Extends Medicare GLP-1 Bridge Through 2027 as Main Program Stalls

Medicare's temporary GLP-1 coverage program gets 18-month extension while the permanent BALANCE model faces uncertainty over insurer participation.

The Dose·May 3, 2026

Novo Nordisk Launches Ozempic Pill in US with $149 Starting Price

By RC Nelson

Editorial cartoon: trending up arrow on teal/yellow waves

FDA Proposes to Block Large-Scale GLP-1 Compounding in Major Access Shift

By The Dose

Editorial cartoon: person walking through doorway on abstract shapes

FDA Opens First Public Review of Revolutionary Fast-Track Drug Program

By The Dose

Editorial cartoon: shield with check mark on green waves

Editorial cartoon: person walking through doorway on abstract shapes

FDA Sends 30 Warning Letters to Telehealth Companies Over Misleading GLP-1 Claims

By GLP1 Clinics News Desk·Apr 28, 2026

Editorial cartoon: trending up arrow on teal/yellow waves

Trump Admin Delays Medicare GLP-1 Coverage After Insurers Balk at Program

By GLP1 Clinics News Desk·Apr 27, 2026

Editorial cartoon: shield with check mark on green waves

FDA Plans July Meeting to Ease Peptide Restrictions After RFK Jr. Push

By RC Nelson·Apr 25, 2026

Editorial cartoon: trending up arrow on teal/yellow waves

Novo's Oral Semaglutide First to Show Promise for Kids with Type 2 Diabetes

By RC Nelson·Apr 24, 2026